Newscast – Page 178 – media

Qfix releases new motion control system for abdomen/thorax

US-based medical devices maker Qfix has introduced its new ZiFix Abdominal/Thoracic Motion Control System designed to stimulate shallow breathing for the management of internal body motion caused due to respiration.
- Source: medicaldevice-network.com
- 385
- August 2, 2017
abdomen Company Insight Qfix thorax
Cardinal buys Medtronic’s Patient Recovery business for $6.1bn

Cardinal Health has concluded the purchase of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business from Medtronic for a total of $6.1bn.
- Source: Medicaldevices-network.com
- 499
- August 1, 2017
Company Insight Market Views patient care
New hepatitis C therapies approved in Europe

Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
- Source: pharmatimes
- 449
- August 1, 2017
hepatitis inhibitor New Approvals
Plexus TG and Codonics to integrate anaesthesia safety technology

Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.
- Source: Medicaldevices-network.com
- 375
- August 1, 2017
anaesthesia Company Insight
AZ, Merck link to develop and commercialise cancer drugs

AstraZeneca and Merck & Co have announced a global strategic oncology collaboration to co-develop and co-commercialise the former’s Lynparza and selumetinib for multiple cancer types.
- Source: pharmatimes
- 500
- July 31, 2017
cancer Lynparza Market Views Researches therapy
EU approves CV benefit claim for Novo’s Victoza

Novo Nordisk’s diabetes drug Victoza is now approved in Europe as the only GLP-1 analogue with a label including prevention of cardiovascular events.
- Source: pharmatimes
- 442
- July 31, 2017
cardiovascular Company Insight diabetes New Approvals
Medtronic launches new MRI cardiac therapy defibrillators

Medtronic’s Canadian subsidiary has launched its new magnetic resonance imaging (MRI) conditional cardiac resynchronisation therapy defibrillators (CRT-Ds)
- Source: Medicaldevices-network.com
- 522
- July 31, 2017
cardiac Company Insight heart MRI
EU OKs first-line use of AZ’ Faslodex

EU regulators are permitting the use of AstraZeneca’s breast cancer drug Faslodex at an earlier stage of the treatment pathway in patients with certain forms of the disease.
- Source: pharmatimes
- 791
- July 28, 2017
breast cancer EU inhibitor New Approvals
Takeda and BioSurfaces to develop new medical devices for GI indications

Japan's Takeda Pharmaceutical Company has signed an agreement with US-based nanotechnology provider BioSurfaces to develop new therapeutic devices to treat gastrointestinal (GI) diseases.
- Source: Medicaldevice-network
- 432
- July 28, 2017
Company Insight gastrointestinal nanofibrous New Approvals
Sensus gets Chinese regulatory approval for keloid device

US-based Sensus Healthcare has received approval from the China Food and Drug Administration (CFDA) to commercialise its keloid prevention and treatment device, SRT-100. The tool is designed to deliver a precise and calibrated dose of superficial radiation therapy to ensure a skin deep and safe treatment for patients. The low-dose radiation is intended to destroy keloid-causing non-malignant tumour cells, basal cell carcinoma and squamous cell carcinoma without the use of anaesthesia, risk of infection, scarring or the need for reconstructive plastic surgery. Sensus intends to introduce SRT-100 into the country’s market in the fourth quarter of this year through its Chinese partner Chindex Medical, which is a division of Fosun Pharma International. The device will focus on prevention and treatment of keloids associated with Cesarean sections (C-sections). Sensus Healthcare CEO Joe Sardano said: “CFDA clearance of the SRT-100 for the treatment and prevention of keloids is an important milestone for ...
- Source: Medicaldevice-network
- 461
- July 28, 2017
CFDA Company Insight keloid New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.